{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-065850","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2026-06-05T20:30:42+00:00","discovered_at":"2026-06-05T20:32:00.239456+00:00","generated_at":"2026-06-05T20:40:46.613500+00:00","sec_items":["3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BiomX issues 1,013,637 shares on partial conversion of Mandragola note; grants 2M-share warrant","bullets":["Issued 1,013,637 restricted shares upon partial conversion of $379K principal under 12% convertible note with Mandragola.","Line of credit agreement dated May 13, 2026 provides up to $2M revolving credit at 12% annual interest.","Issued five-year warrant to Mandragola to purchase 2M shares at $12.00 per share, subject to stockholder approval.","Company now has 11,160,153 shares of common stock outstanding after conversion.","Shares and warrant issued in reliance on Section 4(a)(2) exemption; no general solicitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-065850","json":"https://secwatch.observer/filing/0001213900-26-065850.json","markdown":"https://secwatch.observer/filing/0001213900-26-065850.md","text":"https://secwatch.observer/filing/0001213900-26-065850.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/0001213900-26-065850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/ea0293750-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T20:40:46.613500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29ba071a7d375143d1fe5799a4d11662f29af45c","claim":"BiomX Inc. issued 1,013,637 restricted shares of common stock of common stock to three individual assignees upon partial conversion of a convertible promissory note originally issued to Mandragola Ltd. for conversion of approximately $379,000 in principal amount.","evidence_excerpt":"NYSE American. The warrant was issued to Mandragola in reliance on Section 4(a)(2) of the Securities Act. The Conversion Shares were issued upon the conversion of approximately $379,000 in principal amount extended by Mandragola. The Conversion Shares have not been registered under the Securities Act of 1933 (as amended, the “Securities Act”) or under any state","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/0001213900-26-065850-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"1,013,637 restricted shares of common stock"},{"label":"Purchaser","value":"three individual assignees upon partial conversion of a convertible promissory note originally issued to Mandragola Ltd."},{"label":"Consideration","value":"conversion of approximately $379,000 in principal amount"}],"fact_type":"equity_issuance"},{"claim_id":"ba2f2c521318dda5f7f7c8be9a0c02e2d6c4f8c3","claim":"BiomX Inc. issued up to 2,000,000 shares of Common Stock of warrant to Mandragola Ltd. for additional consideration for making the Credit Line available.","evidence_excerpt":"As additional consideration for making the Credit Line available, the Company also issued to Mandragola a five-year warrant to purchase up to 2,000,000 shares of Common Stock at an exercise price of $12.00 per share, with a cashless exercise feature.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/0001213900-26-065850-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"up to 2,000,000 shares of Common Stock"},{"label":"Purchaser","value":"Mandragola Ltd."},{"label":"Consideration","value":"additional consideration for making the Credit Line available"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}